Immunotropic effects of hypoglycemic agents on coronavirus infection: a view from the perspective of pharmacogenetics | Zendy

К. Г. Гуревич | Zendy; Yu. А. Sorokina | Zendy; Aleksandr Urakov | Zendy; Snezhana D Sinyushkina | Zendy; Maria I. Pryazhnikova | Zendy; A. V. Gorinova | Zendy; Л. В. Ловцова | Zendy; О. В. Занозина | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Immunotropic effects of hypoglycemic agents on coronavirus infection: a view from the perspective of pharmacogenetics

Author(s) -

К. Г. Гуревич,

Yu. А. Sorokina,

Aleksandr Urakov,

Snezhana D Sinyushkina,

Maria I. Pryazhnikova,

A. V. Gorinova,

Л. В. Ловцова,

О. В. Занозина

Publication year - 2022

Publication title -

reviews on clinical pharmacology and drug therapy

Language(s) - English

Resource type - Journals

eISSN - 2542-1875

pISSN - 1683-4100

DOI - 10.17816/rcf203269-279

Subject(s) - pharmacogenetics , medicine , dipeptidyl peptidase 4 , coronavirus , intensive care medicine , type 2 diabetes mellitus , diabetes mellitus , drug , pharmacotherapy , covid-19 , pharmacology , perspective (graphical) , bioinformatics , type 2 diabetes , disease , biology , computer science , genotype , genetics , endocrinology , artificial intelligence , gene , infectious disease (medical specialty)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research